Evidence map›Paper›PMID 35397507›Full record

ArticleBMC infectious diseases2022

Relapsing cellulitis associated with Campylobacter coli bacteremia in a Good's syndrome patient: a case report.

Lei Jiang, Jia Gao, Pu Wang, Yuliang Liu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. The clinical characteristics and outcomes of Campylobacter spp. bloodstream infection: A systematic review and meta-analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lei JiangDepartment of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Jia GaoDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Pu WangDepartment of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yuliang LiuDepartment of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 37428643@qq.com.
Chongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

the In-hospital Cultivation Fund of the First Affiliated Hospital of Chongqing Medical University PYJJ2019-207the Young and Middle-aged High-end Talents Project of the First Affiliated Hospital of Chongqing Medical University 2022GDRC010
6 · The paper itself

Abstract

backgroundGood's syndrome (GS) is characterized by immunodeficiency, and patients diagnosed with GS are susceptible to infection or even bacteremia, which is the most evident complication. Campylobacter coli (C. coli) rarely causes bacteremia or extraintestinal infection. We report herein a case with GS in which right leg cellulitis associated with C. coli bacteremia occurred three times over one and a half years. CASE PRESENTATION: A 41-year-old Chinese male with GS was diagnosed with C. coli infection. He presented with swelling and redness of right lower leg and developed bacteremia due to C. coli repeatedly. Bacteremia was confirmed by bacteriological examination. Adding long-term oral antibiotic treatment with amoxicillin/clavulanate potassium and gentamicin following intravenous meropenem and amikacin was very effective. The blood cultures became negative and the patient has been free from any symptoms encountered for more than one year without relapse of bacteremia.

conclusionsPatients with GS and their physicians should carefully consider the antibacterial treatment options against C. coli bacteremia. Combined anti-infective therapy involving aminoglycoside is preferred in the treatment of C. coli bacteremia in GS patients.

Indexed as

BacteremiaCampylobacter coliCampylobacter InfectionsPrimary Immunodeficiency DiseasesAdultAnti-Bacterial AgentsCellulitisHumansMaleRecurrenceAnti-Bacterial AgentsBacteremiaCampylobacter coliCase reportCellulitis

Identifiers

PMID35397507
PMCPMC8994272
OpenAlexW4223411925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.